@article{1342950b7c7241d3a1dcf38555b612ab,
title = "Canadian Cohort Obstructive Lung Disease (CanCOLD): Fulfilling the need for longitudinal observational studies in COPD",
author = "Jean Bourbeau and Tan, {Wan C.} and Andrea Benedetti and Aaron, {Shawn D.} and Chapman, {Kenneth R.} and Coxson, {Harvey O.} and Robert Cowie and Mark Fitzgerald and Roger Goldstein and Paul Hernandez and Jonathon Leipsic and Francois Maltais and Darcy Marciniuk and Denis O'donnell and Sin, {Don D.}",
note = "Funding Information: The successful completion of this study will only be possible through the commitment of the participants and the dedication of the study personnel from the national coordination and each participating site. The authors wish to thank the Laboratoire de T{\'e}l{\'e}matique Biom{\'e}di-cale du R{\'e}seau en Sant{\'e} Respiratoire du Fonds de la Recherche en Sant{\'e} du Qu{\'e}bec (FRSQ). Funding Information: The Canadian Cohort Obstructive Lung Disease (CanCOLD) is funded by the Canadian Institute of Heath Research (CIHR/Rx&D Collaborative Research Program Operating Grants-93326); industry partners Astra Zeneca Canada Ltd., Boehringer-Ingelheim Canada Ltd., GlaxoSmithKline Canada Ltd, Merck, Novartis Pharma Canada Inc., Nycomed Canada Inc., Pfizer Canada Ltd.; the Respiratory Health Network of the FRSQ and the Research Institute of the McGill University Health Centre.",
year = "2014",
month = apr,
doi = "10.3109/15412555.2012.665520",
language = "English",
volume = "11",
pages = "125--132",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "2",
}